Searle Licenses Beximco’s Remdesivir For Pakistan
Version Of Gilead’s Potential COVID-19 Treatment Already Launched In Bangladesh
Pakistan’s Searle says it has struck a licensing and marketing deal with Bangladesh’s Beximco to market its generic remdesivir in Pakistan as the country grapples with the coronavirus pandemic.
